Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population-Reference-Cited by-同舟云学术

Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population

Published:2023-05 Issue: Volume:372 Page:1-9
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Lin Lijin,Deng Ke-Qiong,Chen Ze,Lei Fang,Qin Juan-Juan,Huang Xuewei,Sun Tao,Zhang Xingyuan,Hu Yingying,Zhang Peng,Ji Yan-Xiao,Zhang Xiao-Jing,She Zhi-Gang,Lu Zhibing,Cai Jingjing,Li Hongliang

Funder

National Natural Science Foundation of China

American Heart Association

Chinese Chemical Society

American College of Cardiology Foundation

Science and Technology Program of Hubei Province

Accident Compensation Corporation

European Atherosclerosis Society

Canadian Cardiovascular Society

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference58 articles.

1. A new serum type system in man--the Lp system;Berg;Acta Pathol. Microbiol. Scand.,1963

2. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies;Tsimikas;J. Am. Coll. Cardiol.,2017

3. Genetic variants associated with Lp(a) lipoprotein level and coronary disease;Clarke;N. Engl. J. Med.,2009

4. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction;Kamstrup;JAMA,2009

5. Estimation of the required lipoprotein(a)-lowering therapeutic effect size for reduction in coronary heart disease outcomes: a mendelian randomization analysis;Lamina;JAMA Cardiol,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies;BMC Medicine;2024-09-05

2. Lipoprotein(a) and cardiovascular disease;The Lancet;2024-09

3. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?;International Journal of Molecular Sciences;2024-03-21

4. LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics;Annual Review of Pharmacology and Toxicology;2024-01-23

5. Measuring lipoprotein(a) for cardiovascular disease prevention – in whom and when?;Current Opinion in Cardiology;2023-11-03